Ensure critical visceral leishmaniasis programs can continue.
Support the END Fund and our partners as we seek to address critical funding opportunities that threaten the delivery of life-saving VL programs.
The Current Situation
Recent changes in the international aid funding landscape have significantly exacerbated the pressures on vital VL programs. The WHO can no longer commit to covering the costs of medicines and diagnostics for VL, leaving a critical funding gap.
VL is one of the most devastating of all neglected tropical diseases, with a fatality rate of more than 95% if untreated. Between 50,000 and 90,000 new cases occur worldwide annually, with children under 15 years old disproportionately affected.
Despite treatments being available that reduce the fatality rate to below 2%, VL continues to particularly affect society's most disadvantaged communities. Accurate diagnoses and access to life-saving treatment remain a major issue for many communities. The END Fund and our partners are working to change this.
You can also donate through one of the following alternative options:
- Online from the UK: via the END Fund's Just Giving page.
- Via Wire Transfer/IRA/Your Legacy: Please contact lparrotta@end.org
- By Check: Addressed to: The END Fund, 2 Park Avenue, 28th floor, New York City, 10016, United States OR The END Fund, 495 Green Lanes, Palmer Green, London, N13 4BS, United Kingdom
- By Stock: Please contact lparrotta@end.org
- Via the Swiss Philanthropy Foundation: The Swiss Philanthropy Foundation will facilitate donations from investors wishing to join our community from Switzerland. For further information, please contact Bridie Layden at blayden@end.org or tge@swissphilanthropy.ch.
Frequently asked questions
Is my donation secure?
Do I get a receipt?
How is my personal data handled?
Our network's tireless efforts in supporting the supply of essential medications, ensuring their efficient distribution, and training healthcare workers in NTD treatment and prevention meant that Loyele found hope at Namoruputh Health Center. There, Loyele received a 17-day course of life-saving injections; each day of treatment a step toward reclaiming his future.